IBM InfoSphere DataStage 8.1/8.5/8.7/9.1/11.3 on Unix access control
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.9 | $0-$5k | 0.00 |
Summary
A vulnerability, which was classified as problematic, has been found in IBM InfoSphere DataStage 8.1/8.5/8.7/9.1/11.3 on Unix. This affects an unknown part. The manipulation leads to access control. This vulnerability is listed as CVE-2015-1900. There is no available exploit.
Details
A vulnerability, which was classified as problematic, has been found in IBM InfoSphere DataStage 8.1/8.5/8.7/9.1/11.3 on Unix (Reporting Software). This issue affects an unknown functionality. The manipulation with an unknown input leads to a access control vulnerability. Using CWE to declare the problem leads to CWE-264. Impacted is confidentiality, integrity, and availability. The summary by CVE is:
IBM InfoSphere DataStage 8.1, 8.5, 8.7, 9.1, and 11.3 through 11.3.1.2 on UNIX allows local users to write to executable files, and consequently obtain root privileges, via unspecified vectors.
The weakness was presented 06/29/2015 (Website). The advisory is shared at www-01.ibm.com. The identification of this vulnerability is CVE-2015-1900 since 02/19/2015. An attack has to be approached locally. No form of authentication is needed for a successful exploitation. Neither technical details nor an exploit are publicly available. The price for an exploit might be around USD $0-$5k at the moment (estimation calculated on 10/15/2017). It is expected to see the exploit prices for this product increasing in the near future.MITRE ATT&CK project uses the attack technique T1068 for this issue.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the databases at SecurityFocus (BID 75481†) and Vulnerability Center (SBV-52072†). If you want to get the best quality for vulnerability data then you always have to consider VulDB.
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.ibm.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 5.9VulDB Meta Temp Score: 5.9
VulDB Base Score: 5.9
VulDB Temp Score: 5.9
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Access controlCWE: CWE-264
CAPEC: 🔍
ATT&CK: 🔍
Physical: Partially
Local: Yes
Remote: No
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
02/19/2015 🔍06/18/2015 🔍
06/18/2015 🔍
06/29/2015 🔍
06/29/2015 🔍
06/30/2015 🔍
08/17/2015 🔍
10/15/2017 🔍
Sources
Vendor: ibm.comAdvisory: www-01.ibm.com
Status: Not defined
Confirmation: 🔍
CVE: CVE-2015-1900 (🔍)
GCVE (CVE): GCVE-0-2015-1900
GCVE (VulDB): GCVE-100-76133
SecurityFocus: 75481 - IBM InfoSphere DataStage CVE-2015-1900 Local Arbitrary Code Execution Vulnerability
Vulnerability Center: 52072 - IBM InfoSphere DataStage 8.1, 8.5, 8.7, 9.1, and 11.3 through 11.3.1.2 on UNIX Local Privileges Escalation Vulnerability, Medium
Entry
Created: 06/30/2015 10:09Updated: 10/15/2017 11:36
Changes: 06/30/2015 10:09 (49), 10/15/2017 11:36 (9)
Complete: 🔍
Cache ID: 216:BA0:103
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
No comments yet. Languages: en.
Please log in to comment.